Subjects with moderately to severely active crohns
1st February 2011
Body: GlaxoSmithKline
Amount: £3,126
People
| Photo | Name | Bio |
|---|---|---|
 |
Professor Christopher Hawkey | Christopher Hawkey is Professor of Gastroenterology at the Nottingham Digestive Diseases Centre. His main interests are in the field of non-steroid anti-inflammatory drugs and inflammatory bowel disease. In both areas his approach is to try to identify… |